Pentwater Capital Management LP, 10% Owner at Tobira Therapeutics, Inc. (TBRA), bought 15,000 shares at $42.10 ($628K) on 2016-10-31, disclosed to the SEC on 2016-11-02.
Open-market purchase of $628k TBRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.71 | 10,000 | $417K | 66.5% |
| 2 | $42.10 | 5,000 | $211K | 33.5% |
| Total | $41.84 avg | 15,000 | $628K | 100% |
| Filing → |
| CAR | SELL | 2026-04-28 | $223.1M | — | Filing → |
| CAR | BUY | 2026-02-24 | $80.1M | — | Filing → |
| TBRA | BUY | 2016-10-19 | $1.6M | — | Filing → |